- ByInvesting.com-
On Tuesday, Evercore ISI adjusted its outlook for Augmedix Inc. (NASDAQ: AUGX), lowering the shares price target to $4.50 from the previous $6.50, while keeping an In Line rating....
Last | Chg. | ||||
---|---|---|---|---|---|
1.90 | +0.72 | +61.02% | 6.7M | ||
0.3431 | +0.1531 | +80.58% | 4.04M | ||
1.34 | +0.26 | +24.07% | 1.93M | ||
0.03 | +0.001 | +3.10% | 717.32K | ||
8.49 | +0.25 | +3.03% | 632.33K | ||
0.83 | +0.25 | +42.47% | 590.12K | ||
3.21 | +0.310 | +10.69% | 493.02K | ||
174.76 | +0.96 | +0.55% | 483.98K | ||
0.1495 | +0.0027 | +1.84% | 335.36K | ||
0.02 | 0.00 | +23.50% | 304.97K |
Name | Last | Chg. % | Vol. |
---|---|---|---|
20.74 | +94.92% | 182.17K | |
0.3431 | +80.58% | 4.04M | |
1.90 | +61.02% | 6.7M | |
18.00 | +53.58% | 0.02K | |
0.83 | +42.47% | 590.12K | |
3.78 | +24.34% | 0 | |
1.34 | +24.07% | 1.93M | |
3.00 | +23.97% | 0.01K | |
0.02 | +23.50% | 304.97K | |
5.21 | +23.46% | 26.64K |
Name | Last | Chg. % | Vol. |
---|---|---|---|
0.1734 | -53.51% | 240.11K | |
1.20 | -21.57% | 0.49K | |
0.91 | -21.53% | 0 | |
0.147 | -19.67% | 136.45K | |
5.64 | -17.06% | 46.25K | |
2.43 | -16.49% | 0.1K | |
0.60 | -15.49% | 1.72K | |
0.22 | -15.38% | 0 | |
0.50 | -14.31% | 25.93K | |
5.57 | -13.78% | 0.15K |
Time | Cur. | Imp. | Event | Actual | Forecast | Previous |
---|---|---|---|---|---|---|
Tuesday, March 19, 2024 | ||||||
08:30 | USD | 1.50M | 1.489M | |||
08:30 | USD | -0.30% | ||||
08:30 | USD | -14.80% | ||||
08:30 | USD | 1.43M | 1.331M | |||
08:55 | USD | 3.00% | ||||
11:30 | USD | 4.695% | ||||
12:30 | USD | 2.30% | 2.30% |
On Tuesday, Evercore ISI adjusted its outlook for Augmedix Inc. (NASDAQ: AUGX), lowering the shares price target to $4.50 from the previous $6.50, while keeping an In Line rating....
Tuesday, shares of Cognizant Technology Solutions (NASDAQ:CTSH) received a neutral rating from Guggenheim as the firm initiated coverage on the information technology services...
Tuesday, Guggenheim initiated coverage on Endava PLC (NYSE:DAVA), a digital services company, with a Buy rating and set a price target of $60.00. The firm sees the recent...
On Tuesday, Evercore ISI adjusted its outlook on System 1 (NYSE:SST), a data-driven marketing company, reducing the price target from $3.00 to $2.00 while maintaining an In Line...
On Tuesday, Citi reaffirmed its Buy rating on KE Holdings stock (NYSE: BEKE), holding the price target steady at $21.10. The firm launched a 90-day positive catalyst watch for the...
The Russell 2000 (IWM) has been defending its 50-day MA over the early part of 2024, but the last few days have seen a shift in this support with 'sell' triggers in the MACD and...
If you had been following the S&P 500 closely this past week, it likely would have left you scratching your head if you were trying to align the news with the market action. For...
Amid upcoming central bank meetings and crucial macroeconomic data releases, market sentiment is poised for potential shifts. While broader market indexes may continue to...
Last week we wrote about how M&A activity has been light so far for 2024, well the same holds for IPO activity. However, next week brings two highly anticipated public debuts that...
This year, the S&P 500 has seen a remarkable streak of 17 new all-time highs, outpacing many previous years. Notably, Warren Buffett's Berkshire Hathaway has stakes in two...